{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:27:38Z","timestamp":1765700858298},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.2353\/jmoldx.2009.080110","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T18:33:44Z","timestamp":1234982024000},"page":"155-161","source":"Crossref","is-referenced-by-count":42,"title":["High Resolution Melting Analysis for JAK2 Exon 14 and Exon 12 Mutations"],"prefix":"10.1016","volume":"11","author":[{"given":"Inmaculada","family":"Rapado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enriqueta","family":"Albizua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Angel","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florinda","family":"Gilsanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Martinez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/jmoldx.2009.080110_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2407-7-168","article-title":"High resolution melting for mutation scanning of TP53 exons 5\u20138","volume":"7","author":"Krypuy","year":"2007","journal-title":"BMC Cancer"},{"key":"10.2353\/jmoldx.2009.080110_bib2","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1373\/clinchem.2007.093781","article-title":"Detection of factor VIII gene mutations by high-resolution melting analysis","volume":"53","author":"Laurie","year":"2007","journal-title":"Clin Chem"},{"key":"10.2353\/jmoldx.2009.080110_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1373\/clinchem.2004.032136","article-title":"Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons","volume":"50","author":"Liew","year":"2004","journal-title":"Clin Chem"},{"key":"10.2353\/jmoldx.2009.080110_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.2353\/jmoldx.2009.080110_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.2353\/jmoldx.2009.080110_bib6","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.2353\/jmoldx.2009.080110_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.2353\/jmoldx.2009.080110_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080110_bib9","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2353\/jmoldx.2009.080110_bib10","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood-2007-07-101576","article-title":"Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders","volume":"111","author":"Pietra","year":"2008","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080110_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.2353\/jmoldx.2009.080110_bib12","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/sj.leu.2404419","article-title":"Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera","volume":"20","author":"Grunebach","year":"2006","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080110_bib13","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.leu.2404325","article-title":"Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: d620E and E627E","volume":"20","author":"Schnittger","year":"2006","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080110_bib14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080110_bib15","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1182\/blood-2005-09-3900","article-title":"X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET\/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis","volume":"107","author":"Levine","year":"2006","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080110_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hon.800","article-title":"A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood","volume":"24","author":"Poodt","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.2353\/jmoldx.2009.080110_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00277-008-0512-x","article-title":"Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases","volume":"87","author":"Rapado","year":"2008","journal-title":"Ann Hematol"},{"key":"10.2353\/jmoldx.2009.080110_bib18","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.leu.2404292","article-title":"The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors","volume":"20","author":"Sidon","year":"2006","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2009.080110_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1373\/clinchem.2006.066886","article-title":"Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant","volume":"52","author":"Sidon","year":"2006","journal-title":"Clin Chem"},{"key":"10.2353\/jmoldx.2009.080110_bib20","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080110_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4065\/82.5.599","article-title":"Evaluation of increased hemoglobin in the JAK2 mutations era","volume":"82","author":"Tefferi","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.2353\/jmoldx.2009.080110_bib22","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2009.080110_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2257.2006.00864.x","article-title":"The investigation of JAK2 mutation in Chinese myeloproliferative diseases-identification of a novel C616Y point mutation in a PV patient","volume":"29","author":"Zhang","year":"2007","journal-title":"Int J Lab Hematol"},{"key":"10.2353\/jmoldx.2009.080110_bib24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3324\/haematol.12883","article-title":"Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis","volume":"93","author":"Jones","year":"2008","journal-title":"Haematologica"},{"key":"10.2353\/jmoldx.2009.080110_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2V617F: prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810602218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810602218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T18:54:47Z","timestamp":1545418487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157810602218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1525157810602218"],"URL":"https:\/\/doi.org\/10.2353\/jmoldx.2009.080110","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}